Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daheng He

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|February 1, 2025
Metformin in overcoming enzalutamide resistance in castration-resistant prostate cancerKendall Simpson, Derek B Allison, Daheng He, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 8, 2024
Metformin in Overcoming Enzalutamide Resistance in Castration-Resistant Prostate CancerKendall Simpson, Derek B Allison, Daheng He, et al.
The Prostate|July 21, 2023
Downregulation of EZH2 inhibits epithelial-mesenchymal transition in enzalutamide-resistant prostate cancerZhuangzhuang Zhang, Xinyi Wang, Miyeong Kim, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
PLK1 phosphorylates WRN at replication forksLei Wang, Daheng He, Qianjin Li, et al.
The Journal of Biological Chemistry|October 18, 2018
Sirtuin 1-mediated deacetylation of XPA DNA repair protein enhances its interaction with ATR protein and promotes cAMP-induced DNA repair of UV damageStuart G Jarrett, Katharine M Carter, Robert-Marlo Bautista, et al.
Urologic Oncology|July 22, 2019
Predictive value of phenotypic signatures of bladder cancer response to cisplatin-based neoadjuvant chemotherapyPatrick J Hensley, Natasha Kyprianou, Matthew S Purdom, et al.
Oncogene|July 8, 2026
SETDB1-mediated repression of RhoB promotes EMT and metastatic progression in prostate cancerHan Cong, Fatemeh Seilani, Ryan Goettl, et al.
Cancers|November 9, 2024
Integrin α6β4 Upregulates PTPRZ1 Through UCHL1-Mediated Hif-1α Nuclear Accumulation to Promote Triple-Negative Breast Cancer Cell Invasive PropertiesMin Chen, Parvanee A Karimpour, Andrew Elliott, et al.
American Journal of Clinical and Experimental Urology|July 19, 2019
Predictive and targeting value of IGFBP-3 in therapeutically resistant prostate cancerPatrick J Hensley, Zheng Cao, Hong Pu, et al.
JAMA Network Open|April 1, 2021
Association Between Obesity and Histological Tumor Budding in Patients With Nonmetastatic Colon CancerTong Gan, Kurt B Schaberg, Daheng He, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Pharmacology and Experimental Therapeutics|February 1, 2025
Metformin in overcoming enzalutamide resistance in castration-resistant prostate cancerKendall Simpson, Derek B Allison, Daheng He, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 8, 2024
Metformin in Overcoming Enzalutamide Resistance in Castration-Resistant Prostate CancerKendall Simpson, Derek B Allison, Daheng He, et al.
The Prostate|July 21, 2023
Downregulation of EZH2 inhibits epithelial-mesenchymal transition in enzalutamide-resistant prostate cancerZhuangzhuang Zhang, Xinyi Wang, Miyeong Kim, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
PLK1 phosphorylates WRN at replication forksLei Wang, Daheng He, Qianjin Li, et al.
The Journal of Biological Chemistry|October 18, 2018
Sirtuin 1-mediated deacetylation of XPA DNA repair protein enhances its interaction with ATR protein and promotes cAMP-induced DNA repair of UV damageStuart G Jarrett, Katharine M Carter, Robert-Marlo Bautista, et al.
Urologic Oncology|July 22, 2019
Predictive value of phenotypic signatures of bladder cancer response to cisplatin-based neoadjuvant chemotherapyPatrick J Hensley, Natasha Kyprianou, Matthew S Purdom, et al.
Oncogene|July 8, 2026
SETDB1-mediated repression of RhoB promotes EMT and metastatic progression in prostate cancerHan Cong, Fatemeh Seilani, Ryan Goettl, et al.
Cancers|November 9, 2024
Integrin α6β4 Upregulates PTPRZ1 Through UCHL1-Mediated Hif-1α Nuclear Accumulation to Promote Triple-Negative Breast Cancer Cell Invasive PropertiesMin Chen, Parvanee A Karimpour, Andrew Elliott, et al.
American Journal of Clinical and Experimental Urology|July 19, 2019
Predictive and targeting value of IGFBP-3 in therapeutically resistant prostate cancerPatrick J Hensley, Zheng Cao, Hong Pu, et al.
JAMA Network Open|April 1, 2021
Association Between Obesity and Histological Tumor Budding in Patients With Nonmetastatic Colon CancerTong Gan, Kurt B Schaberg, Daheng He, et al.
Pageof 6